Fault for high-priced drugs lies with drug makers | BenefitsPRO

Instead of simply acknowledging their pricing strategies, drug companies and their lobbyists have launched a finger pointing campaign at pharmacy benefit managers (PBMs).

Source: Fault for high-priced drugs lies with drug makers | BenefitsPRO